Obg-like ATPase 1 regulates global protein serine/threonine phosphorylation in cancer cells by suppressing the GSK3β-inhibitor 2-PP1 positive feedback loop
Metrics: PDF 704 views | HTML 940 views | ?
Dong Xu2, Renduo Song1, Guohui Wang1, Prince V.S. Jeyabal1, Amanda M. Weiskoff1, Kefeng Ding2, Zheng-Zheng Shi1
1Department of Translational Imaging, Houston Methodist Research Institute, Houston, TX 77030, USA
2Department of Surgical Oncology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310009, China
Zheng-Zheng Shi, e-mail: firstname.lastname@example.org
Keywords: cell signaling, GSK3beta, protein phosphatase 1, positive feedback loop, OLA1
Received: August 17, 2015 Accepted: November 21, 2015 Published: December 07, 2015
OLA1 is an Obg family P-loop NTPase that possesses both GTP- and ATP-hydrolyzing activities. Here we report that OLA1 is a GSK3β interacting protein, and through its ATPase activity, inhibits the GSK3β-mediated activation of protein serine/threonine phosphatase 1 (PP1). It is hypothesized that GSK3β phosphorylates inhibitor 2 (I-2) of PP1 at Thr-72 and activates the PP1 · I-2 complex, which in turn dephosphorylates and stimulates GSK3β, thus forming a positive feedback loop. We revealed that the positive feedback loop is normally suppressed by OLA1, and becomes over-activated under OLA1 deficiency, resulting in increased cellular PP1 activity and dephosphorylation of multiple Ser/Thr phosphoproteins, and more strikingly, decreased global protein threonine phosphorylation. Furthermore, using xenograft models of colon cancer (H116) and ovarian cancer (SKOV3), we established a correlation among downregulation of OLA1, over-activation of the positive feedback loop as indicated by under-phosphorylation of I-2, and more aggressive tumor growth. This study provides the first evidence for the existence of a GSK3β-I-2-PP1 positive feedback loop in human cancer cells, and identifies OLA1 as an endogenous suppressor of this signaling motif.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.